Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells
Abstract Liver fibrosis is a critical liver disease that can progress to more severe manifestations, such as cirrhosis, yet no effective targeted therapies are available. Here, we identify that ATF4, a master transcription factor in ER stress response, promotes liver fibrosis by facilitating a stres...
Saved in:
Main Authors: | Li-Xian Yang, Chuangye Qi, Si Lu, Xiang-Shi Ye, Parnaz Merikhian, Du-Yu Zhang, Tao Yao, Jiang-Sha Zhao, Ying Wu, Yongshi Jia, Bo Shan, Jinghai Chen, Xiaozhou Mou, Jia You, Wenbo Li, Yu-Xiong Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55738-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological Microenvironment‐Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes‐Hepatic Stellate Cells Malignant Crosstalk
by: Ling‐Feng Zhang, et al.
Published: (2025-01-01) -
AdipoRon mitigates liver fibrosis by suppressing serine/glycine biosynthesis through ATF4-dependent glutaminolysis
by: Xiangting Zhang, et al.
Published: (2025-01-01) -
Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10
by: Ya-Hui Wang, et al.
Published: (2017-01-01) -
Sphingosine Kinase 1 – A Therapeutic Opportunity for Alleviating Liver Fibrosis?
by: Jia Ming Nickolas Teo, et al.
Published: (2025-01-01) -
YBX1 alleviates ferroptosis in osteoporosis via the ATF4/FSP1 axis in an m5C manner
by: Lei Tong, et al.
Published: (2025-01-01)